Position in PFE
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$11,754,098
-$4,975,403 QoQ
Shares Held
488,127
-18.1% QoQ
Ownership
0.009%
of shares outstanding
% of Portfolio
0.19%
of 13F equity value
Holder Rank
#380
of 2,820 holders
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026ALLSTATE CORP holds $290,077,256 across 10 Drug Manufacturers - General names. PFE ranks #8 (4.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
75,805 | $90,922,797 | |
| 2 | JNJ |
Johnson & Johnson
|
249,928 | $63,474,214 | |
| 3 | ABBV |
AbbVie Inc.
|
185,629 | $46,711,681 | |
| 4 | MRK |
Merck & Co., Inc.
|
225,796 | $29,014,786 | |
| 5 | AMGN |
Amgen Inc
|
52,252 | $18,921,494 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
107,859 | $13,626,905 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
210,034 | $12,102,159 | |
| 8 | PFE |
Pfizer Inc
This page
|
488,127 | $11,754,098 |
All Filings in PFE
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,754,098 | 488,127 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $16,729,501 | 595,780 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $10,424,086 | 418,638 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $5,202,888 | 204,195 | Shares | Sole | 2025-10-29 | |
| 2025-06-30 | $214,766 | 8,860 | Shares | Sole | 2025-08-05 | |
| 2025-03-31 | $5,632,144 | 222,263 | Shares | Sole | 2025-05-14 | |
| 2024-12-31 | $4,456,403 | 167,976 | Shares | Sole | 2025-02-12 | |
| 2024-06-30 | $444,098 | 15,872 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $388,777 | 14,010 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $577,037 | 20,043 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $645,322 | 19,455 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $713,609 | 19,455 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $799,394 | 19,593 | Shares | Sole | 2023-05-10 | |
| 2022-12-31 | $11,722,123 | 228,769 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $9,873,875 | 225,637 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $11,885,933 | 226,701 | Shares | Sole | 2022-08-15 | |
| 2022-03-31 | $22,311,109 | 430,966 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $24,058,918 | 407,433 | Shares | Sole | 2022-02-15 | |
| 2021-09-30 | $4,628,091 | 107,605 | Shares | Sole | 2021-11-15 | |
| 2021-06-30 | $4,520,121 | 115,427 | Shares | Sole | 2021-08-16 | |
| 2021-03-31 | $4,766,418 | 131,560 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $4,885,018 | 132,709 | Shares | Sole | 2021-02-12 | |
| 2020-09-30 | $4,623,608 | 125,984 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $4,818,873 | 147,366 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,188,936 | 158,975 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||